Innlanz Ltd (inl) Logo

Innlanz Ltd (INL)

___:___ · Consumer Cyclical
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

INL Chart

Snapshot

INL's Principal Activity is the the Group operates a retail business, with four retail outlets in Australia and New Zealand focused on serving inbound Chinese tourists, who typically visit the outlets during an organised group tour.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +17.22%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,685 of 2,423
Sector Rank 120 of 150

Key Fundamentals

Shares Issued
Sector Consumer Cyclical
Similar Companies MPH / UCW / EDU
EPS -$0.004
DPS $0.00
Book Value Per Share $0.01

Broker Consensus

INL is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Innlanz Limited (INL , formerly Mediland Pharm Limited)operates in a retail business, with four retail outlets in Australia and New Zealand focused on serving inbound Chinese tourists, who typically visit the outlets during an organised group tour.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Parramatta NSW 2150
Website www.medilandpharm.com.au
Registry Computershare
Auditor BDO Audit Pty Ltd
Date Listed 22 Feb 2019

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Prelim)
28/10/2022 Report (Annual)
28/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Leo (Xiaolei) Cui Non-Executive Director Nov 2019

Mr Leo (Xiaolei) Cui

Non-Executive Director

Mr Cui has experience in Financial Services Industry mainly responsible for Group Dealing, Risk Management, responsibility for compliance with respect to ASIC and specific compliance obligations under Australian Financial Services License. Previous work experience also includes sales and marketing, financial product advice to and dealing with wholesale and retail clients, derivative products and foreign exchange contracts. He is a member of the Risk committee.

Mr Theo Noel Renard Non-Executive Director Jan 2019

Mr Theo Noel Renard

Non-Executive Director

Mr Renard has over 20 years of experience in credit and relationship banking in commercial and investment banking with Nedcor in South Africa and Asia and ABN AMRO in Australia and Asia. He spent over two years as CFO and Company Secretary with a retail group with retail and manufacturing operations in Asia and the Subcontinent, during that time he was a Director of several of the listed companies and affiliates. Mr Renard has over 10 years experience in the resources sector as Chief Financial Officer and Company Secretary. He is Chair of the risk committee.

Dr Peter W French Non-Executive Chairman,Non-Executive Director Nov 2018

Dr Peter W French

Non-Executive Chairman,Non-Executive Director

Dr French is an experienced senior executive and director in public and private companies primarily in the biotechnology and healthcare sector. He is a member of the Risk committee.

Mrs Tracey Lee Cray Non-Executive Director Aug 2018

Mrs Tracey Lee Cray

Non-Executive Director

Mrs Cray has over 16 years of experience in the hospitality and tourism industry. Working with hotel brands including Choice Hotels, IHG, Mantra Group and Accor, including franchise operating models. She works in the areas of operational and compliance requirements in Human Resources, Workplace Health and Safety, Learning and Development, Holistic Customer Service and Brand Awareness. She is a member of the Risk committee.

Mr Jhon Shen Executive Director Aug 2018

Mr Jhon Shen

Executive Director

Mr Shen is a businessman with experience of developing profitable businesses and incubating new business opportunities through acquisition in the retail, tourism, travel and hospitality sectors. He has experience within the Chinese retail sector, as he worked in both operational and management level within the Company since March 2015.

Mr Yeshween Mudaliar Managing Director Aug 2018

Mr Yeshween Mudaliar

Managing Director

Mr Mudaliar has 16 years of industry experience. Over the past 16 years, he has fulfilled senior executive roles with hotel chains including Marriott, Accor and IHG, in both managed and franchise operational models. He progressed his career to an asset management and business acquisition specialist.

Ms Indira Naidu Company Secretary N/A
Jessie Tao Chief Financial Officer N/A

Director Transactions

INL directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
03/02/22 Tracey Cray Buy +16,666 $0.06 $999 As advised by the company
03/02/22 Tracey Cray Buy +150,000 $0.067 $10,000 Conversion of securities
03/02/22 Tracey Cray Exercise 150,000 $0.067 $10,000 Conversion of securities
03/02/22 Theo Renard Buy +16,666 $0.06 $999 As advised by the company
03/02/22 Theo Renard Buy +150,000 $0.067 $10,000 Conversion of securities
03/02/22 Theo Renard Exercise 150,000 $0.067 $10,000 Conversion of securities
03/02/22 Peter French Buy +16,666 $0.06 $999 As advised by the company
03/02/22 Peter French Buy +150,000 $0.067 $10,000 Conversion of securities
03/02/22 Peter French Exercise 150,000 $0.067 $10,000 Conversion of securities
02/02/22 Tracey Cray Issued 150,000 $0.06 $9,000 Issue of securities
02/02/22 Theo Renard Issued 150,000 $0.06 $9,000 Issue of securities
02/02/22 Peter French Issued 150,000 $0.06 $9,000 Issue of securities

Director Interests

The current holdings of INL directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Tracey Cray 03/02/2022 166,666 N/A N/A N/A
Theo Renard 03/02/2022 166,666 N/A N/A N/A
Peter French 03/02/2022 150,000 N/A N/A N/A
Leo (Xiaolei) Cui 30/06/2021 61,000 N/A N/A N/A
Jhon Shen 30/06/2021 N/A 250,000,000 N/A N/A
Yeshween Mudaliar 27/08/2018 2,500,000 2,500,000 N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 15, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Pacific Merchants Group Limited 250,000,000 79.93%
Mr Qiming Du 13,190,811 4.22%
Mr Yongqiang Lu 10,000,000 3.20%
Ms Xiyao Sun 10,000,000 3.20%
Aussia Pharmaceuticals Pty Ltd <Yan Family A/C> 2,700,000 0.86%
Yun Liu 2,536,236 0.81%
Ms Ming Xu <Xu Family A/C> 2,500,000 0.80%
Wei Liu 1,999,910 0.64%
Mr Zhixiong Li 1,997,105 0.64%
Mrs Li Chen 1,000,000 0.32%
Ms Jun Yan 1,000,000 0.32%
Lei Wang 1,000,000 0.32%
Weiqing Ye 1,000,000 0.32%
Ms Xiyao Sun (i) 950,383 0.30%
Xinjia Cui 855,600 0.27%
Ms Yi Liu 764,000 0.24%
Mr Tissa Wijesuriya 600,000 0.19%
Yuanbo Lian 500,000 0.16%
Mr Eldo Nirakkallungal Pappachan + Ms Riby Kuriachan <N P Family A/C> 400,000 0.13%
Mr Chuang Wang 354,467 0.11%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 10 43 88 147 39 327

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Pacific Merchants Group Limited 15/09/2021 250,000,000 79.93

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
INL Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.